Mænd med rejsningsbesvær efter radikal prostatektomi bør behandles efter sædvanlige retningslinjer

Mikkel Fode; Rikke Bølling Hansen; Thomas Maigaard; Jens Sønksen

Mænd med rejsningsbesvær efter radikal prostatektomi bør behandles efter sædvanlige retningslinjer

Translated title of the contribution: Treatment of erectile dysfunction after radical prostatectomy should be in accordance with standard regimens.

Mikkel Fode, Rikke Bølling Hansen, Thomas Maigaard, Jens Sønksen

Department of Urology

1 Citation (Scopus)

Abstract

Penile rehabilitation programmes aim to improve long-term sexual function after nerve-sparing radical prostatectomy. Programmes aim to improve cavernous oxygenation to avoid structural damage in penile tissue. Especially, daily use of phosphodiesterase type 5 (PDE5) inhibitors has been studied. The method is effective in animal models, but the results cannot be confirmed in humans. At this time, treatment regimens which actually create erections and allow for sexual intercourse following surgery should be prescribed. These include PDE5 inhibitors, vacuum erection devices, injection therapy, urethral suppositories and penile implants.

Translated title of the contribution	Treatment of erectile dysfunction after radical prostatectomy should be in accordance with standard regimens.
Original language	Danish
Article number	3
Journal	Ugeskrift for læger [online]
Issue number	3
Pages (from-to)	243-244
Number of pages	2
ISSN	1603-6824
Publication status	Published - 10 Feb 2014

Cite this

@article{0153c57be4724a729d5e84b8969252db,

title = "M{\ae}nd med rejsningsbesv{\ae}r efter radikal prostatektomi b{\o}r behandles efter s{\ae}dvanlige retningslinjer",

abstract = "Penile rehabilitation programmes aim to improve long-term sexual function after nerve-sparing radical prostatectomy. Programmes aim to improve cavernous oxygenation to avoid structural damage in penile tissue. Especially, daily use of phosphodiesterase type 5 (PDE5) inhibitors has been studied. The method is effective in animal models, but the results cannot be confirmed in humans. At this time, treatment regimens which actually create erections and allow for sexual intercourse following surgery should be prescribed. These include PDE5 inhibitors, vacuum erection devices, injection therapy, urethral suppositories and penile implants.",

author = "Mikkel Fode and Hansen, \{Rikke B{\o}lling\} and Thomas Maigaard and Jens S{\o}nksen",

year = "2014",

month = feb,

day = "10",

language = "Dansk",

pages = "243--244",

journal = "Ugeskrift for l{\ae}ger [online]",

issn = "1603-6824",

publisher = "Almindelige Danske L{\ae}geforening",

number = "3",

}

TY - JOUR

T1 - Mænd med rejsningsbesvær efter radikal prostatektomi bør behandles efter sædvanlige retningslinjer

AU - Fode, Mikkel

AU - Hansen, Rikke Bølling

AU - Maigaard, Thomas

AU - Sønksen, Jens

PY - 2014/2/10

Y1 - 2014/2/10

N2 - Penile rehabilitation programmes aim to improve long-term sexual function after nerve-sparing radical prostatectomy. Programmes aim to improve cavernous oxygenation to avoid structural damage in penile tissue. Especially, daily use of phosphodiesterase type 5 (PDE5) inhibitors has been studied. The method is effective in animal models, but the results cannot be confirmed in humans. At this time, treatment regimens which actually create erections and allow for sexual intercourse following surgery should be prescribed. These include PDE5 inhibitors, vacuum erection devices, injection therapy, urethral suppositories and penile implants.

AB - Penile rehabilitation programmes aim to improve long-term sexual function after nerve-sparing radical prostatectomy. Programmes aim to improve cavernous oxygenation to avoid structural damage in penile tissue. Especially, daily use of phosphodiesterase type 5 (PDE5) inhibitors has been studied. The method is effective in animal models, but the results cannot be confirmed in humans. At this time, treatment regimens which actually create erections and allow for sexual intercourse following surgery should be prescribed. These include PDE5 inhibitors, vacuum erection devices, injection therapy, urethral suppositories and penile implants.

UR - https://www.scopus.com/pages/publications/84989208920

M3 - Tidsskriftartikel

C2 - 25347560

SN - 1603-6824

SP - 243

EP - 244

JO - Ugeskrift for læger [online]

JF - Ugeskrift for læger [online]

IS - 3

M1 - 3

ER -

Mænd med rejsningsbesvær efter radikal prostatektomi bør behandles efter sædvanlige retningslinjer

Abstract

Other files and links

Fingerprint

Cite this